市場調查報告書
商品編碼
1401210
脈搏血氧計全球市場規模、佔有率、產業趨勢分析報告:2023-2030 年按最終用戶、類型和地區分類的展望和預測Global Pulse Oximeter Market Size, Share & Industry Trends Analysis Report By End User (Hospitals & Clinics, Homecare and Others), By Type (Fingertip, Handheld, Wrist worn, Bedside, and Others), By Regional Outlook and Forecast, 2023 - 2030 |
預計到 2030 年,全球脈搏血氧計市場規模將達到 34 億美元,預測期內複合年成長率為 6.3%。 2022年市場規模為1404.36萬輛,成長18.0%(2019-2022年)。
此外,疫情導致對脈搏血氧計的需求激增,特別是在早期階段,呼吸道症狀是 COVID-19 患者主要關注的問題。個人和醫療機構尋求這些設備來監測家庭和臨床環境中的氧氣水平。很大一部分 COVID-19 患者有中度症狀或無症狀,促使家庭監測廣泛普及。脈搏血氧計對於患者自我監測和醫療保健專業人員遠端追蹤患者的氧氣水平都至關重要。不斷成長的需求刺激了市場的創新和產品開拓。醫療保健製造商探索了新功能和技術,以滿足醫療保健專業人員和消費者不斷變化的需求。因此,COVID-19的爆發對市場產生了正面的影響。
然而,在以較高的醫療基礎設施和意識為特徵的新興市場中,對特定醫療設備的需求往往達到飽和狀態。在這樣的成熟市場中,很大一部分目標人口可能已經擁有或能夠使用脈搏血氧計,這限制了市場擴張的新機會。在已開發地區,脈搏血氧儀普及廣泛,普及較高。大多數人,包括醫療機構和個人,可能已經擁有這些設備,從而降低了額外銷售的可能性。例如,將呼吸健康監測擴展到運動和健身應用,或將脈搏血氧儀整合到穿戴式裝置中可以吸引新的使用者群體。這些方面可能會限制市場的成長。
最終用戶前景
根據最終用戶,市場分為醫院/診所、居家照護等。 2022年,居家照護領域在市場中獲得了可觀的收益佔有率。患者便利性、經濟效率以及在熟悉的環境中管理慢性病的能力等因素正在推動在家中提供醫療保健的運動。脈搏血氧計提供了一種實用且非侵入性的方法來監測家庭中的氧氣水平。世界人口高齡化正在增加慢性呼吸道疾病和各種其他健康併發症的發生率。尤其是老年人,可能會受益於在家中監測血氧飽和度,脈搏血氧儀在這一人群中的採用率正在增加。因此,該細分市場預計將在未來幾年內迅速擴張。
類型展望
依類型分類,市場可分為手持式、指尖式、腕戴式、床邊式等。 2022年,指尖細分市場佔據了市場最大的收益佔有率。遠端患者監護的普及,尤其是在大流行期間,促進了指尖脈搏血氧計的普及。患者可以在家中輕鬆使用這些設備,並將資料傳輸給醫療保健提供者,從而實現遠端監控和介入。從這個角度來看,該細分市場的需求預計將會增加。
區域展望
從區域來看,市場分為北美、歐洲、亞太地區、拉丁美洲、中東和非洲。 2022 年,北美市場的收益佔有率最高。北美,尤其美國,是世界上醫療保健支出最高的地區之一。成熟的醫療基礎設施和對醫療技術的大量投資正在促進脈搏血氧計等先進醫療設備的採用。這些方面可能為該行業提供良好的成長前景。
The Global Pulse Oximeter Market size is expected to reach $3.4 billion by 2030, rising at a market growth of 6.3% CAGR during the forecast period. In the year 2022, the market attained a volume of 14,043.6 thousand units, experiencing a growth of 18.0% (2019-2022).
Pulse oximeters offer a user-friendly tool for patients to monitor their oxygen levels at home, fostering a sense of control and early intervention. Therefore, the Homecare segment acquired $690.8 million in 2022. Pulse oximeters provide a non-invasive and immediate way to measure oxygen saturation levels, enabling patients and healthcare professionals to monitor respiratory health regularly. Patients are increasingly becoming proactive in managing their health, and awareness campaigns have empowered individuals to take charge of their respiratory well-being. Some of the factors impacting the market are increasing remote patient monitoring, rising aging population around the world, and increasing saturation in various nations.
Home healthcare allows individuals, especially those with chronic conditions, to monitor their health without frequent visits to healthcare facilities. Pulse oximeters offer a convenient and accessible way for individuals to track their oxygen levels in the comfort of their homes. Patients with chronic respiratory conditions, such as COPD and asthma, often require continuous monitoring of their oxygen saturation levels. Home use of pulse oximeters facilitates regular monitoring, enabling individuals and their healthcare providers to manage chronic conditions more effectively. Additionally, respiratory conditions, such as chronic obstructive pulmonary disease (COPD), pneumonia, and other lung diseases, become more prevalent with age. The aging process can affect lung function, making older individuals more susceptible to respiratory challenges. Aging individuals may not always exhibit obvious symptoms of respiratory problems until the conditions have progressed. Pulse oximeters provide a non-invasive and quick way to assess oxygen saturation levels, enabling early detection of potential respiratory issues before they become severe. Pulse oximeters support this preference by offering a tool for home monitoring. Seniors can regularly check their oxygen levels, promoting independence and proactive health management. These factors will drive the demand for pulse oximeters in the coming years.
Further, the pandemic led to a surge in demand for pulse oximeters, especially during the early stages when respiratory symptoms were a primary concern for COVID-19 patients. Individuals and healthcare facilities sought these devices to monitor oxygen levels at home and clinical settings. A considerable proportion of COVID-19 patients exhibited moderate symptoms or were asymptomatic, which contributed to the increasing prevalence of home monitoring. Pulse oximeters became essential for patients to self-monitor and for healthcare professionals to track patients' oxygen levels remotely. The increased demand prompted innovation and product development in the market. Manufacturers explored new features and technologies to meet the evolving needs of healthcare professionals and consumers. Therefore, the COVID-19 pandemic positively impacted the market.
However, developed markets, characterized by high healthcare infrastructure and awareness, often reach a saturation point for certain medical devices. In these mature markets, a large proportion of the target population may already own or have access to pulse oximeters, limiting new opportunities for market expansion. The widespread adoption of pulse oximeters in developed regions results in high penetration rates. Many of the population, including healthcare facilities and individuals, may already possess these devices, reducing the potential for additional sales. For example, expanding beyond respiratory health monitoring to sports and fitness applications or integrating pulse oximeters into wearable devices may attract new user segments. These aspects can restrain the growth of the market.
End User Outlook
Based on end user, the market is segmented into hospitals & clinics, homecare, and others. In 2022, the homecare segment garnered a significant revenue share in the market. A more extensive movement has emerged towards healthcare provided at home, motivated by factors such as patient convenience, financial efficiency, and the capacity to oversee chronic ailments in a familiar environment. Pulse oximeters offer a practical and non-intrusive method for monitoring oxygen levels in one's residence. The worldwide population is aging, leading to an increased incidence of chronic respiratory conditions and various other health complications. Older people, in particular, may benefit from monitoring their oxygen saturation levels at home, leading to increased adoption of pulse oximeters in this demographic. Therefore, the segment will expand rapidly in the coming years.
Type Outlook
On the basis of type, the market is divided into handheld, fingertip, wrist worn, bedside, and others. In 2022, the fingertip segment witnessed the maximum revenue share in the market. The growth of remote patient monitoring practices, especially during the pandemic, contributed to the popularity of fingertip pulse oximeters. Patients could easily use these devices at home, with the data transmitted to healthcare providers for remote monitoring and intervention. These aspects will lead to increased demand in the segment.
Regional Outlook
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America, particularly the United States, has one of the highest healthcare spending levels globally. The well-established healthcare infrastructure and significant investments in medical technology contribute to the adoption of advanced medical devices like pulse oximeters. These aspects will pose lucrative growth prospects for the segment.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hill-Rom Holdings, Inc. (Welch Allyn) (Baxter International, Inc.), GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Nonin Medical, Inc., ICU Medical, Inc. (Smiths Medical), Medtronic PLC, OSI Systems, Inc. (Spacelabs Healthcare), Nihon Kohden Corporation, Meditech Equipment Co.,Ltd (Meditech Group), and Honeywell International, Inc.
Market Segments covered in the Report:
By End User (Volume, Thousand Units, USD billion, 2019-2030)
By Type (Volume, Thousand Units, USD billion, 2019-2030)
By Geography (Volume, Thousand Units, USD billion, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research